Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04960956 · ClinicalTrials.gov registry record
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 13
- Enrollment target
NCT04960956 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 13 participants.
The verdict
NCT04960956 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to collect a urine sample from patients with prostate and urothelial (bladder) cancer and healthy volunteers who do not have cancer, so that researchers can perform studies on microcellular structures called exosomes that may eventually lead to a new type of urinary biomarker test for prostate and urothelial cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-10-13 |
| Est. Completion | 2017-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04960956
The ClinicalTrials.gov registry entry for NCT04960956 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04960956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04960956 about?
NCT04960956 is a clinical study titled "Glycosylation of Exosomes in Prostate and Urothelial Carcinoma". The purpose of this study is to collect a urine sample from patients with prostate and urothelial (bladder) cancer and healthy volunteers who do not have cancer, so that researchers can perform studies on microcellular structures called exosomes that may eventually lead to a new type of urinary biom...
What is the current status of trial NCT04960956?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2016-10-13. Estimated completion is 2017-02-02.
Who is sponsoring clinical trial NCT04960956?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.